8-KOther Events

HCA Healthcare, Inc. 8-K Report (Jul 26, 2004)

Filed July 26, 2004For Securities:HCA

Summary

This 8-K filing from HCA Healthcare, Inc. (HCA), filed on July 26, 2004, primarily serves to disclose the company's financial results for the second quarter ended June 30, 2004, as detailed in an accompanying press release (Exhibit 99.1). While the 8-K itself does not provide the granular details of the results, it signals that important operational and financial performance information has been made public. Investors should refer to the referenced press release (Exhibit 99.1) for comprehensive details on HCA's performance during the second quarter of 2004. This filing is a key indicator for stakeholders to access updated financial data, understand the company's operational trends, and make informed investment decisions based on the latest reported outcomes.

Key Highlights

  • 1HCA Healthcare, Inc. filed an 8-K Current Report on July 26, 2004.
  • 2The filing discloses the company's results of operations for the second quarter ended June 30, 2004.
  • 3The detailed financial results are provided in a press release, which is filed as Exhibit 99.1.
  • 4The report includes information relevant to Regulation FD disclosure.
  • 5Item 12 of the filing specifically addresses Results of Operations and Financial Condition.
  • 6Investors are directed to Exhibit 99.1 for the specific financial and operational performance data for Q2 2004.

Frequently Asked Questions

The primary purpose of this 8-K filing is to publicly disclose HCA Healthcare's financial results for the second quarter ended June 30, 2004, in compliance with Regulation FD. The detailed results are contained within an attached press release.

The specific financial and operational results for the second quarter ended June 30, 2004, are detailed in the press release filed as Exhibit 99.1 to this 8-K report.

No, this 8-K filing itself does not contain the detailed financial statements. It serves as a notification that the company has released its quarterly results via a press release, which is attached as Exhibit 99.1 and should be reviewed for financial details.

Regulation FD (Fair Disclosure) requires that when a public company discloses material non-public information to securities analysts or other securities professionals, it must make that information available to the public simultaneously. This 8-K filing, by attaching the press release, ensures that the Q2 2004 results are publicly disseminated.